@article{6aa826dc6aeb47f8a5e9fcb203c434d1,
title = "IL-33 signaling in sensory neurons promotes dry skin itch",
abstract = "Background: Chronic pruritus, or itch, is common and debilitating, but the neuroimmune mechanisms that drive chronic itch are only starting to be elucidated. Recent studies demonstrate that the IL-33 receptor (IL-33R) is expressed by sensory neurons. However, whether sensory neuron–restricted activity of IL-33 is necessary for chronic itch remains poorly understood. Objectives: We sought to determine if IL-33 signaling in sensory neurons is critical for the development of chronic itch in 2 divergent pruritic disease models. Methods: Plasma levels of IL-33 were assessed in patients with atopic dermatitis (AD) and chronic pruritus of unknown origin (CPUO). Mice were generated to conditionally delete IL-33R from sensory neurons. The contribution of neuronal IL-33R signaling to chronic itch development was tested in mouse models that recapitulate key pathologic features of AD and CPUO, respectively. Results: IL-33 was elevated in both AD and CPUO as well as their respective mouse models. While neuron-restricted IL-33R signaling was dispensable for itch in AD-like disease, it was required for the development of dry skin itch in a mouse model that mirrors key aspects of CPUO pathology. Conclusions: These data highlight how IL-33 may be a predominant mediator of itch in certain contexts, depending on the tissue microenvironment. Further, this study provides insight into future therapeutic strategies targeting the IL-33 pathway for chronic itch.",
keywords = "Atopic dermatitis, IL-33, chronic pruritus of unknown origin, dry skin, itch, neuroimmunology, pruriceptor, pruritogen",
author = "Trier, {Anna M.} and Mack, {Madison R.} and Avery Fredman and Masato Tamari and {Ver Heul}, {Aaron M.} and Yonghui Zhao and Guo, {Changxiong J.} and Oshri Avraham and Ford, {Zachary K.} and Oetjen, {Landon K.} and Jing Feng and Carina Dehner and Dean Coble and Asima Badic and Satoru Joshita and Masato Kubo and Gereau, {Robert W.} and Jennifer Alexander-Brett and Valeria Cavalli and Steve Davidson and Hongzhen Hu and Qin Liu and Kim, {Brian S.}",
note = "Funding Information: Research in the Kim laboratory is supported by the Celgene Corporation , Doris Duke Charitable Foundation , LEO Pharma , and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ( K08AR065577 , R01AR070116 , R01AR077007 , and R21AI167047 ) (to B.S.K.). A.M.T. and M.R.M. are supported by National Institute of Allergy and Infectious Diseases (NIAID) ( T32AI007163 ). A.M.T. and L.K.O. are supported by National Heart, Lung, and Blood Institute (NHLBI) ( T32HL007317 ). A.M.T. is supported by NIAID ( F30AI154912 ). Research in the Gereau laboratory involving human dorsal root ganglia research is supported by National Institute of Neurological Disorders and Strokes (NINDS) ( R01NS042595 ) (to R.W.G.). Research in the Alexander-Brett laboratory is supported by NHLBI ( R01HL152245 ) and the Burroughs Welcome Fund ( 1014685 ) (to J.A.B). Research in the Cavalli laboratory is supported by the McDonnell Center for Cellular and Molecular Neurobiology and NINDS (R01NS111719) (to V.C.). O.A. is supported by the postdoctoral fellowship from the McDonnell Center for Cellular and Molecular Neurobiology. Research in the Davidson laboratory is supported by NINDS ( RF1NS113881 ) (to S.D.). Research in the Hu laboratory is supported by National Institute for Alcohol Abuse and Alcoholism (NIAAA) ( R01AA027065 ), NIAMS ( R01AR077183 ), and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ( R01DK103901 ) (to H.H.). Additional support was provided by the Washington University School of Medicine Digestive Disease Research Core Center (NIDDK, P30DK052574). Research in the Liu laboratory is supported by NIAID (R01AI125743), Brain Research Foundation Fay/Frank Seed Grant, and Pew Scholar Award (to Q.L.). Support with flow cytometry and Luminex was provided by the Bursky Center for Human Immunology & Immunotherapy Programs at Washington University, Immunomonitoring Laboratory (IML). The IML is a shared resource of the Alvin J. Siteman Cancer Center (Washington University School of Medicine and Barnes-Jewish Hospital in St Louis), which is supported in part by the National Cancer Institute (P30CA091842). Publisher Copyright: {\textcopyright} 2021 The Authors",
year = "2022",
month = apr,
doi = "10.1016/j.jaci.2021.09.014",
language = "English",
volume = "149",
pages = "1473--1480.e6",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "4",
}